Evommune Inc (EVMN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | |
| Sales | 7,000 |
| Gross Profit | 7,000 |
| Operating Income | 7,000 |
| Pre-tax Income | 7,000 |
| Net Income Continuous | -66,808 |
| Net Income | $-66,808 |
| EPS Basic Total Ops | -45.29 |
| EPS Basic Continuous Ops | -44.30 |
| EPS Diluted Total Ops | -45.29 |
| EPS Diluted Continuous Ops | -44.30 |
| EPS Diluted Before Non-Recurring Items | -45.29 |
| EBITDA(a) | $7,000 |